The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(1,1'-biphenyl-3-yl)-1-[dihydroxy(oxido)-lambda~4~-sulfanyl]ethylphosphonic acid ID: ALA199653
PubChem CID: 11559213
Max Phase: Preclinical
Molecular Formula: C14H15O6PS
Molecular Weight: 342.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=P(O)(O)C(Cc1cccc(-c2ccccc2)c1)S(=O)(=O)O
Standard InChI: InChI=1S/C14H15O6PS/c15-21(16,17)14(22(18,19)20)10-11-5-4-8-13(9-11)12-6-2-1-3-7-12/h1-9,14H,10H2,(H2,15,16,17)(H,18,19,20)
Standard InChI Key: VOMUWPIMENALLG-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
-3.3681 -14.2458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3693 -15.0732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6544 -15.4860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9380 -15.0727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9409 -14.2422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6562 -13.8330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2279 -13.8270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5119 -14.2368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5088 -15.0618 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.5167 -15.8833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3162 -15.0642 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3338 -15.0628 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0806 -13.8336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0794 -13.0075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7932 -12.5953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.5085 -13.0080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.5057 -13.8373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7913 -14.2458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2010 -13.8216 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
0.9125 -13.4042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6173 -14.5338 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2153 -13.1093 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9 11 2 0
5 6 2 0
9 12 1 0
6 1 1 0
1 2 2 0
13 14 2 0
5 7 1 0
14 15 1 0
3 4 2 0
15 16 2 0
7 8 1 0
16 17 1 0
17 18 2 0
18 13 1 0
1 13 1 0
8 9 1 0
8 19 1 0
4 5 1 0
19 20 2 0
9 10 2 0
19 21 1 0
2 3 1 0
19 22 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 342.31Molecular Weight (Monoisotopic): 342.0327AlogP: 2.29#Rotatable Bonds: 5Polar Surface Area: 111.90Molecular Species: ACIDHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: -0.74CX Basic pKa: ┄CX LogP: 1.63CX LogD: -3.06Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.57Np Likeness Score: 0.03
References 1. Kotsikorou E, Song Y, Chan JM, Faelens S, Tovian Z, Broderick E, Bakalara N, Docampo R, Oldfield E.. (2005) Bisphosphonate inhibition of the exopolyphosphatase activity of the Trypanosoma brucei soluble vacuolar pyrophosphatase., 48 (19): [PMID:16162013 ] [10.1021/jm058220g ] 2. Hudock MP, Sanz-Rodríguez CE, Song Y, Chan JM, Zhang Y, Odeh S, Kosztowski T, Leon-Rossell A, Concepción JL, Yardley V, Croft SL, Urbina JA, Oldfield E.. (2006) Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates., 49 (1): [PMID:16392806 ] [10.1021/jm0582625 ]